Journal of Clinical Pediatrics >
Genetic diagnosis and management of TRPV4 disorders
Received date: 2022-12-06
Online published: 2023-02-16
TRPV4 disorders are a group of disorders with the same disease-causing gene but highly heterogeneous phenotypes. TRPV4 disorders can be divided into two different subgroups: neuromuscular disorders and skeletal dysplasia. TRPV4 disorders were clinically classified as multiple independent disorders before their molecular basis was discovered. Therefore, genetic testing is of great significance for the diagnosis and management of TRPV4 disorders. This paper reviews the characteristics of TRPV4 and each disorder, genetic testing methods, genotype-phenotype correlation information and management after diagnosis, providing ideas for the diagnosis and treatment of TRPV4 disorders.
Xuyun HU , Chanjuan HAO . Genetic diagnosis and management of TRPV4 disorders[J]. Journal of Clinical Pediatrics, 2023 , 41(2) : 86 -91 . DOI: 10.12372/jcp.2023.22e1621
| [1] | White JP, Cibelli M, Urban L, et al. TRPV4: molecular conductor of a diverse orchestra[J]. Physiol Rev, 2016, 96(3): 911-973. |
| [2] | Alessandri-Haber N, Yeh JJ, Boyd AE, et al. Hypotonicity induces TRPV4-mediated nociception in rat[J]. Neuron, 2003, 39(3): 497-511. |
| [3] | Benfenati V, Amiry-Moghaddam M, Caprini M, et al. Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes[J]. Neuroscience, 2007, 148(4):876-892. |
| [4] | Konno M, Shirakawa H, Iida S, et al. Stimulation of transient receptor potential vanilloid 4 channel suppresses abnormal activation of microglia induced by lipopolysaccharide[J]. Glia, 2012, 60(5): 761-770. |
| [5] | Willard VP, Leddy HA, Palmer D, et al. Transient receptor potential vanilloid 4 as a regulator of induced pluripotent stem cell chondrogenesis[J]. Stem Cells, 2021, 39(11): 1447-1456. |
| [6] | Mizoguchi F, Mizuno A, Hayata T, et al. Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss[J]. J Cell Physiol, 2008, 216(1): 47-53. |
| [7] | McNulty AL, Leddy HA, Liedtke W, et al. TRPV4 as a therapeutic target for joint diseases[J]. Naunyn Schmiedebergs Arch Pharmacol, 2015, 388(4): 437-450. |
| [8] | Klein CJ, Cunningham JM, Atkinson EJ, et al. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders[J]. Neurology, 2003, 60(7): 1151-1156. |
| [9] | Deng HX, Klein CJ, Yan J, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4[J]. Nat Genet, 2010, 42(2): 165-169. |
| [10] | Echaniz-Laguna A, Dubourg O, Carlier P, et al. Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy[J]. Neurology, 2014, 82(21): 1919-1926. |
| [11] | Mortier GR, Cohn DH, Cormier-Daire V, et al. Nosology and classification of genetic skeletal disorders: 2019 revision[J]. Am J Med Genet A, 2019, 179(12): 2393-2419. |
| [12] | Nishimura G, Lausch E, Savarirayan R, et al. TRPV4-associated skeletal dysplasias[J]. Am J Med Genet C Semin Med Genet, 2012, 160C(3): 190-204. |
| [13] | Inada H, Procko E, Sotomayor M, et al. Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel[J]. Biochemistry, 2012, 51(31): 6195-6206. |
| [14] | D'Hoedt D, Owsianik G, Prenen J, et al. Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3[J]. J Biol Chem, 2008, 283(10): 6272-6280. |
| [15] | Garcia-Elias A, Mrkonjic S, Pardo-Pastor C, et al. Phosphatidylinositol-4,5-biphosphate-dependent rearrangement of TRPV4 cytosolic tails enables channel activation by physiological stimuli[J]. Proc Natl Acad Sci U S A, 2013, 110(23): 9553-9558. |
| [16] | Hu X, Li N, Xu Y, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience[J]. Genet Med, 2018, 20(9): 1045-1053. |
| [17] | Hu X, Guo R, Guo J, et al. Parallel tests of whole exome sequencing and copy number variant sequencing increase the diagnosis yields of rare pediatric disorders[J]. Front Genet, 2020, 11: 473. |
| [18] | Yao R, Zhang C, Yu T, et al. Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data[J]. Mol Cytogenet, 2017, 10: 30. |
| [19] | Velilla J, Marchetti MM, Toth-Petroczy A, et al. Homozygous TRPV4 mutation causes congenital distal spinal muscular atrophy and arthrogryposis[J]. Neurol Genet, 2019, 5(2): e312. |
| [20] | Thibodeau ML, Peters CH, Townsend KN, et al. Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy[J]. Am J Med Genet A, 2017, 173(11): 3087-3092. |
| [21] | Unger S, Lausch E, Stanzial F, et al. Fetal akinesia in metatropic dysplasia: The combined phenotype of chondrodysplasia and neuropathy?[J]. Am J Med Genet A, 2011, 155A(11): 2860-2864. |
| [22] | Nilius B, Voets T. The puzzle of TRPV4 channelopathies[J]. EMBO Rep, 2013, 14(2): 152-163. |
| [23] | Sullivan JM, Zimanyi CM, Aisenberg W, et al. Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy[J]. Neurol Genet, 2015, 1(4): e29. |
| [24] | Auer-Grumbach M, Olschewski A, Papic L, et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C[J]. Nat Genet, 2010, 42(2): 160-164. |
| [25] | Landoure G, Zdebik AA, Martinez TL, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C[J]. Nat Genet, 2010, 42(2): 170-174. |
| [26] | Dai J, Kim O H, Cho T J, et al. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family[J]. J Med Genet, 2010, 47(10): 704-709. |
| [27] | Krakow D, Vriens J, Camacho N, et al. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia[J]. Am J Hum Genet, 2009, 84(3): 307-315. |
| [28] | Loukin SH, Teng J, Kung C. A channelopathy mechanism revealed by direct calmodulin activation of TrpV4[J]. Proc Natl Acad Sci U S A, 2015, 112(30): 9400-9405. |
| [29] | Cho TJ, Matsumoto K, Fano V, et al. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients[J]. Am J Med Genet A, 2012, 158A(4): 795-802. |
| [30] | Faye E, Modaff P, Pauli R, et al. Combined phenotypes of spondylometaphyseal Dysplasia-Kozlowski type and Charcot-Marie-Tooth disease type 2C secondary to a TRPV4 pathogenic variant[J]. Mol Syndromol, 2019, 10(3): 154-160. |
| [31] | Chen DH, Sul Y, Weiss M, et al. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene[J]. Neurology, 2010, 75(22): 1968-1975. |
| [32] | Rahbari R, Wuster A, Lindsay S J, et al. Timing, rates and spectra of human germline mutation[J]. Nat Genet, 2016, 48(2): 126-133. |
/
| 〈 |
|
〉 |
